In a recent study, researchers examined the relapse rate and possible influencing factors—including treatment with rituximab—in patients with autoimmune thrombotic thrombocytopenic purpura.
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
For this study, the researchers examined the risk factors for bleeding in adults with immune thrombocytopenia, including the platelet count thresholds. To see their results, read more.
The authors of a new study recently aimed to explore the incidence of postoperative venous thromboembolism among more than 750,000 surgical patients who underwent blood transfusions.
The authors of a new study recently aimed to explore the incidence of postoperative venous thromboembolism among more than 750,000 surgical patients who underwent blood transfusions.
Previous research has shown fatigue as a key morbidity in patients with thrombocytopenia, but there is limited information on the full impact of ITP on patient’s quality of life.
Previous research has shown fatigue as a key morbidity in patients with thrombocytopenia, but there is limited information on the full impact of ITP on patient’s quality of life.